Human SOCS3 knockout THP-1 cell line

Human SOCS3 knockout THP-1 cell line

Cat. No.: DCL-001035

Size: 1 × 106 cells/vial Size: Customer Size
Product Information
Parental THP-1
Organism Human
Tissue Blood
Target Name SOCS3
Cell Type Acute monocytic leukemia
Gender Male
UniProt No. O14543
Gene ID 9021
Gene Description SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS3 is involved in negative regulation of cytokines that signal through the JAK/STAT pathway. Inhibits cytokine signal transduction by binding to tyrosine kinase receptors including gp130, LIF, erythropoietin, insulin, IL12, GCSF and leptin receptors. Binding to JAK2 inhibits its kinase activity. Suppresses fetal liver erythropoiesis. Regulates onset and maintenance of allergic responses mediated by T-helper type 2 cells. Regulates IL-6 signaling in vivo (By similarity). Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Seems to recognize IL6ST.
Format Frozen
Growth Properties Suspension
Shipping & Storage
Shipping Cryopreserved on dry ice.
Storage Instructions Store in liquid nitrogen.
Storage Buffer/Media 8.7% Dimethylsulfoxide, 2% Cellulose, methyl ether
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top